AVID BIOSERVICES INC. - COMMON STOCK

Avid Bioservices to be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion Transaction

06 11月 2024 17:04:07 条件 Nasdaq GlobeNewswire

Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference

12 9月 2024 15:05:27 条件 Nasdaq GlobeNewswire

Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024

09 9月 2024 15:05:31 条件 Nasdaq GlobeNewswire

Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024

03 9月 2024 15:05:20 条件 Nasdaq GlobeNewswire

Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024

02 7月 2024 15:05:04 条件 Nasdaq GlobeNewswire

Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024

01 7月 2024 06:00:21 条件 Nasdaq GlobeNewswire

Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance

23 5月 2024 07:05:46 条件 Nasdaq GlobeNewswire

Avid Bioservices to Participate at Upcoming Investor Conferences

07 5月 2024 15:05:11 条件 Nasdaq GlobeNewswire

Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024

24 4月 2024 16:25:33 条件 Nasdaq GlobeNewswire

Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q

20 3月 2024 06:00:10 条件 Nasdaq GlobeNewswire

Avid Bioservices Announces Pricing of Private Placement of Convertible Notes

06 3月 2024 22:58:48 条件 Nasdaq GlobeNewswire

Avid Bioservices Announces Proposed Private Placement of Convertible Notes

06 3月 2024 15:32:07 条件 Nasdaq GlobeNewswire

Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024

06 3月 2024 15:31:28 条件 Nasdaq GlobeNewswire

Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2023

07 12月 2023 15:05:38 条件 Nasdaq GlobeNewswire

Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2024 After Market Close on December 7, 2023

30 11月 2023 15:05:57 条件 Nasdaq GlobeNewswire

Avid Bioservices Partners With California Institute for Regenerative Medicine (CIRM) to Provide CDMO Services for Cell and Gene Therapy (CGT) Programs

08 11月 2023 07:05:03 条件 Nasdaq GlobeNewswire

Avid Bioservices Completes Construction of New, World-Class Cell and Gene Therapy Development and Manufacturing Facility

17 10月 2023 07:05:09 条件 Nasdaq GlobeNewswire

Avid Bioservices to Participate in RBC Capital Markets Virtual CDMO Conference

26 9月 2023 15:05:51 条件 Nasdaq GlobeNewswire

Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2023

07 9月 2023 15:05:25 条件 Nasdaq GlobeNewswire

Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2024 After Market Close on September 7, 2023

31 8月 2023 15:05:10 条件 Nasdaq GlobeNewswire